VOL. 48, 2004
1,2-DITHIOLE-3-ONES AS FabH INHIBITORS
3101
4. Baum, E. Z., D. A. Montenegro, L. Licata, I. Turchi, G. C. Webb, B. D.
Foleno, and K. Bush. 2001. Identification and characterization of new inhib-
itors of the Escherichia coli MurA enzyme. Antimicrob. Agents Chemother.
45:3182–3188.
31. Joshi, A. K., A. Witkowski, and S. Smith. 1997. Mapping of functional
interactions between domains of the animal fatty acid synthase by mutant
complementation in vitro. Biochemistry 36:2316–2322.
32. Kellogg, G. E., S. F. Semus, and D. J. Abraham. 1991. HINT: a new method
of empirical hydrophobic field calculation for CoMFA. J. Comput. Aided
Mol. Des. 5:545–552.
33. Kensler, T. W., J. D. Groopman, T. R. Sutter, T. J. Curphey, and B. D.
Roebuck. 1999. Development of cancer chemopreventive agents: oltipraz as
a paradigm. Chem. Res. Toxicol. 12:113–126.
¨
5. Boberg, F. 1965. Uber 1.2-dithia-cyclopentene. VII. 4-Chlor-5-amino-1.2-
dithia-cyclopentenone-(3). Liebigs Ann. Chem. 681:169–177.
6. Boberg, F., and M. Ghoudikian. 1975. 1,2-Dithiacyclopentene. XXVII. 2-
Chloromethylene-1,3-dithioles from 4-chloro-3H-1,2-dithiol-3-ones; prepa-
ration and mechanism. Liebigs Ann. Chem. 1975:1513–1520.
7. Boberg, F., M. Ghoudikian, and M. H. Khorgam. 1974. On 1,2-dithia-cyclo-
pentenes. XXVI. Ring cleavage of 5-chloro-3H-1,2-dithiole-3-ones by Grig-
nard compounds. Liebigs Ann. Chem. 1974:1261–1268.
34. Khandekar, S. S., D. R. Gentry, G. S. Van Aller, P. Warren, H. Xiang, C.
Silverman, M. L. Doyle, A. K. Konstantinidis, M. Brandt, R. A. Daines, and
J. T. Lonsdale. 2001. Identification, substrate specificity, and inhibition of the
Streptococcus pneumoniae -ketoacyl-acyl carrier protein synthase III
(FabH). J. Biol. Chem. 274:30024–30030.
35. Khanna, S., C. K. Sen, S. Roy, M. O. Christen, and L. Packer. 1998. Pro-
tective effects of anethole dithiolethione against oxidative stress-induced
cytotoxicity in human Jurkat T cells. Biochem. Pharmacol. 56:61–69.
36. Klingsberg, E. 1972. The 1,2-dithiolium cation. XI. Polycyclic dithiole and
“no-bond resonance” compounds. J. Org. Chem. 37:3226–3229.
37. Kremer, L., J. D. Douglas, A. R. Baulard, C. Morehouse, M. R. Guy, D.
Alland, L. G. Dover, J. H. Lakey, W. R. Jacobs, Jr., P. J. Brennan, D. E.
Minnikin, and G. S. Besra. 2000. Thiolactomycin and related analogues as
novel anti-mycobacterial agents targeting KasA and KasB condensing en-
zymes in Mycobacterium tuberculosis. J. Biol. Chem. 275:16857–16864.
38. Kuhajda, F. P. 2000. Fatty-acid synthase and human cancer: new perspec-
tives on its role in tumor biology. Nutrition 16:202–208.
39. Kuhajda, F. P., E. S. Pizer, J. N. Li, N. S. Mani, G. L. Frehywot, and C. A.
Townsend. 2000. Synthesis and antitumor activity of an inhibitor of fatty acid
synthase. Proc. Natl. Acad. Sci. USA 97:3450–3454.
40. Langouet, S., L. L. Furge, N. Kerriguy, K. Nakamura, A. Guillouzo, and F. P.
Guengerich. 2000. Inhibition of human cytochrome P450 enzymes by 1,2-
dithiole-3-thione, oltipraz and its derivatives, and sulforaphane. Chem. Res.
Toxicol. 13:245–252.
¨
8. Boberg, F., and J. Knoop. 1967. Uber 1.2-dithia-cyclopentene. XI. 1.2-Di-
thia-cyclopentenone-(3) aus trithionen. Liebigs Ann. Chem. 708:148–154.
¨
9. Boberg, F., H. Niemann, and J. Jovanovic. 1968. Uber 1.2-dithia-cyclopen-
tene. XIII. Befunde zur dithiacyclobuten-bzw. thiacyclopropen-zwischen-
stufe und synthese von 1.4-dipiperidino-2.3-dimethoxycarbonylbutadien-
(1.3). Liebigs Ann. Chem. 717:154–168.
10. Bourzat, J. D., C. Cotrel, D. Farge, J. M. Paris, and G. Taurand. 1985.
Derivatives of 1,2-dithiole-3-one and medicinal compositions containing
them. French patent 2541679.
11. Carey, K. A., T. W. Kensler, and J. C. Fishbein. 2001. Kinetic constraints for
the thiolysis of 4-methyl-5-(pyrazin-2-yl)-1,2-dithiole-3-thione (oltipraz) and
related dithiole-3-thiones in aqueous solution. Chem. Res. Toxicol. 14:939–
945.
12. Chirala, S. S., M. A. Kuziora, D. M. Spector, and S. J. Wakil. 1987. Comple-
mentation of mutations and nucleotide sequence of FAS1 gene encoding
beta-subunit of yeast fatty acid synthase. J. Biol. Chem. 262:4231–4240.
13. Choi, K. H., R. J. Heath, and C. O. Rock. 2000. -Ketoacyl-acyl carrier
protein synthase III (FabH) is a determining factor in branched-chain fatty
acid biosynthesis. J. Bacteriol. 182:365–370.
14. Choi, K. H., L. Kremer, G. S. Besra, and C. O. Rock. 2000. Identification and
substrate specificity of beta-ketoacyl (acyl carrier protein) synthase III
(mtFabH) from Mycobacterium tuberculosis. J. Biol. Chem. 275:28201–28207.
15. Clark, M., R. D. I. Cramer, and N. Van Opdenbosch. 1989. The Tripos force
field. J. Comput. Chem. 10:982–1012.
41. Largeron, M., T. Martens, and M. B. Fleury. 1987. Reactivity of substituted
1,2-dithiole-3-thiones with sodium ethanethiolate: a convenient route to a
novel heterocycle. Tetrahedron Lett. 43:3421–3428.
16. Clough, R. C., M. Matthis, S. R. Barnum, and J. G. Jaworski. 1992. Purifi-
cation and characterization of 3-ketoacyl-acyl carrier protein synthase III
from spinach; a condensing enzyme utilizing acetyl coenzyme A to initiate
fatty acid synthesis. J. Biol. Chem. 267:20992–20998.
17. Curphey, T. J. 2000. A superior procedure for the conversion of 3-oxoesters
to 3H-1,2-dithiole-3-thiones. Tetrahedron Lett. 41:9963–9966.
18. Curphey, T. J. 2002. Thionation of esters and lactones with the reagent
combination of phosphorous pentasulfide and hexamethyldisiloxane. Tetra-
hedron Lett. 43:371–373.
42. Lobo, S., G. Florova, and K. A. Reynolds. 2001. A Streptomyces collinus
thiolase with novel acetyl-CoA:acyl carrier protein transacylase activity. Bio-
chemistry 40:11955–11964.
43. Magnusson, K., S. Jackowski, C. O. Rock, and J. E. Cronan. 1993. Regula-
tion of fatty acid biosynthesis in Escherichia coli. Microbiol. Rev. 57:522–542.
44. Maxuitenko, Y. Y., A. H. Libby, H. H. Joyner, T. J. Curphey, D. L. MacMil-
lan, T. W. Kensler, and B. D. Roebuck. 1998. Identification of dithiolethiones
with better chemopreventive properties than oltipraz. Carcinogenesis 19:
1609–1615.
19. Curphey, T. J. 2002. Thionation with the reagent combination of phospho-
rous pentasulfide and hexamethyldisiloxane. J. Org. Chem. 67:6461–6473.
20. Daines, R. A., I. Pendrak, K. Sham, G. S. Van Aller, A. K. Konstantinidis,
J. T. Lonsdale, C. A. Janson, X. Qiu, M. Brandt, S. S. Khandekar, C. Sil-
verman, and M. S. Head. 2003. First X-ray cocrystal structure of a bacterial
FabH condensing enzyme and a small molecule inhibitor achieved using
rational design and homology modeling. J. Med. Chem. 46:5–8.
21. Davies, C., R. J. Heath, S. W. White, and C. O. Rock. 2000. The 1.8 A crystal
structure and active-site architecture of beta-ketoacyl-acyl carrier protein
synthase III (FabH) from Escherichia coli. Struct. Fold Des. 8:185–195.
22. DeBarber, A. E., K. Mdluli, M. Bosman, L. G. Bekker, and C. E. Barry III.
2000. Ethionamide activation and sensitivity in multidrug-resistant Mycobac-
terium tuberculosis. Proc. Natl. Acad. Sci. USA 97:9677–9682.
23. Douglas, J. D., S. J. Senior, C. Morehouse, B. Phetsukiri, I. B. Campbell,
G. S. Besra, and D. E. Minnikin. 2002. Analogues of thiolactomycin: poten-
tial drugs with enhanced anti-mycobacterial activity. Microbiology 148:3101–
3109.
24. Fleury, M. B., and M. Largenon. 1985. Studies on the reaction of 1,2-
dithiole-3-thiones with nucleophiles. Tetrahedron 41:3705–3715.
25. Han, L., S. Lobo, and K. A. Reynolds. 1998. Characterization of beta-
ketoacyl-acyl carrier protein synthase III from Streptomyces glaucescens and
its role in initiation of fatty acid biosynthesis. J. Bacteriol. 180:4481–4486.
26. He, X., J. P. Mueller, and K. A. Reynolds. 2000. Development of a scintil-
lation proximity assay for beta-ketoacyl-acyl carrier protein synthase III.
Anal. Biochem. 282:107–114.
45. McFadden, J. M., G. L. Frehywot, and C. A. Townsend. 2002. A flexible route
to (5R)-thiolactomycin, a naturally occurring inhibitor of fatty acid synthesis.
Org. Lett. 4:3859–3862.
46. Nagano, T., and M. Takeyama. 2001. Enhancement of salivary secretion and
neuropeptide (substance P, alpha-calcitonin gene-related peptide) levels in
saliva by chronic anethole trithione treatment. J. Pharm. Pharmacol. 53:
1697–1702.
47. Nishida, I., A. Kawaguchi, and M. Yamada. 1986. Effect of thiolactomycin on
the individual enzymes of the fatty acid synthase system in Escherichia coli.
J. Biochem. 99:1447–1454.
48. Pagani, G., M. Pregnolato, D. Ubiali, M. Terreni, C. Piersimoni, F. Scagli-
one, F. Fraschini, A. R. Gascon, and J. L. P. Munoz. 2000. Synthesis and
in vitro anti-mycobacterium activity of N-alkyl-1,2-dihydro-2-thioxo-3-pyri-
dinecarbothioamides. Preliminary toxicity and pharmacokinetic evaluation.
J. Med. Chem. 43:199–204.
49. Parikh, S. L., G. Xiao, and P. J. Tonge. 2000. Inhibition of InhA, the enoyl
reductase from Mycobacterium tuberculosis, by triclosan and isoniazid. Bio-
chemistry 39:7645–7650.
50. Pedersen, B. S., and S.-O. Lawesson. 1979. Studies on organophosphorous
compounds. XXVIII. Synthesis of 3H-1,2-dithiole-3-thiones and 4H-1,3,2-
oxazaphosphorine derivatives from the dimer of methoxyphenylthionophos-
phine sulfide and derivatives of 3-oxocarboxylic acids. Tetrahedron 35:2433–
2437.
51. Pedersen, C. T. 1995. 1,2-Dithiole-3-thiones and 1,2-dithiol-3-ones. Sulfur
Rep. 16:173–221.
27. He, X., and K. A. Reynolds. 2002. Purification, characterization, and identi-
fication of novel inhibitors of the beta-ketoacyl-acyl carrier protein synthase
III (FabH) from Staphylococcus aureus. Antimicrob. Agents Chemother.
46:1310–1318.
28. Heath, R. J., J. Li, G. E. Roland, and C. O. Rock. 2000. Inhibition of the
Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reduc-
tase by triclosan and hexachlorophene. J. Biol. Chem. 275:4654–4659.
29. Heath, R. J., S. W. White, and C. O. Rock. 2001. Lipid biosynthesis as a target
for antibacterial agents. Prog. Lipid Res. 40:467–497.
52. Price, A. C., K. H. Choi, R. J. Heath, Z. Li, S. W. White, and C. O. Rock.
2000. Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolacto-
mycin and cerulenin: structure and mechanism. J. Biol. Chem. 276:6551–
6559.
53. Prigge, S. T., X. He, L. Gerena, N. C. Waters, and K. A. Reynolds. 2003. The
initiating steps of a type II fatty acid synthase in Plasmodium falciparum are
catalyzed by pfACP, pfMCAT, and pfKASIII. Biochemistry 42:1160–1169.
54. Qiu, X., C. A. Janson, A. K. Konstantinidis, S. Nwagwu, C. Silverman, W. W.
Smith, S. Khandekar, J. Lonsdale, and S. S. Abdel-Meguid. 1999. Crystal
structure of beta-ketoacyl-acyl carrier protein synthase III. A key condensing
enzyme in bacterial fatty acid biosynthesis. J. Biol. Chem. 274:36465–36471.
55. Qiu, X., C. A. Janson, W. W. Smith, M. Head, J. Lonsdale, and A. K.
30. Jones, A. L., J. E. Dancer, and J. L. Harwood. 1994. The effect of thiolac-
tomycin analogues on fatty acid synthesis in peas (Pisum sativum). Biochem.
Soc. Trans. 22:285.